Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  51 results for ""Hydroxymethylglutaryl-CoA Reductase Inhibitors""

Your Filters

Language : french Format : Academic Journals Subject : anticholesteremic agents Subject : drug side effects
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

[First-line treatment of hypercholesterolemia : start with statin monotherapy or ezetimibe-statin combination ?]

  • Authors : Scheen A; Service de Diabétologie, Nutrition et Maladies métaboliques, CHU Liège, Belgique.; Wallemacq C

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Azetidines*/Azetidines*/Azetidines*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: Revue medicale de Liege [Rev Med Liege] 2024 Apr; Vol. 79 (4), pp. 202-207.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[Evolocumab (Repatha®) : new therapy ofhypercholesterolaemia for secondary prevention of atherosclerotic disease].

  • Authors : Scheen A; Service de Diabétologie, Nutrition et Maladies métaboliques, CHU Liège, Belgique.; Wallemacq C

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/chemically induced

  • Source: Revue medicale de Liege [Rev Med Liege] 2023 Oct; Vol. 78 (10), pp. 593-600.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapy].

  • Authors : Scheen AJ; Service de Diabétologie, Nutrition et Maladies métaboliques, Département de Médecine interne, CHU Liège, Belgique.; Wallemacq C

Subjects: Cardiovascular Diseases* ; Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/pharmacology ; Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use

  • Source: Revue medicale de Liege [Rev Med Liege] 2022 Dec; Vol. 77 (12), pp. 745-751.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[A practitioner's perspective of the latest lipid guidelines].

  • Authors : Ponet L; Service de médecine de premier recours, Département de médecine de premiers recours, Hôpitaux universitaires de Genève, 1211 Genève 14.; Franchetti L

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control

  • Source: Revue medicale suisse [Rev Med Suisse] 2022 Sep 28; Vol. 18 (797), pp. 1802-1805.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Bempedoïc acid, new cholesterol-lowering drug].

  • Authors : Scheen AJ; Service de Diabétologie, Nutrition et Maladies métaboliques , CHU Liège, Belgique.; Paquot N

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Pharmaceutical Preparations*

  • Source: Revue medicale de Liege [Rev Med Liege] 2022 Feb; Vol. 77 (2), pp. 124-131.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[Long-lasting LDL-C lowering: silence at last].

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors* ; Hyperlipoproteinemia Type II*

  • Source: Revue medicale suisse [Rev Med Suisse] 2021 May 26; Vol. 17 (740), pp. 1039-1046.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[A decade of progress in the management of dyslipidemia].

  • Authors : Wallemacq C; ) Service de Diabétologie, Nutrition et Maladies métaboliques, CHU Liège, Belgique.; Paquot N

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Cardiovascular Diseases* ; Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/drug therapy

  • Source: Revue medicale de Liege [Rev Med Liege] 2020 May; Vol. 75 (5-6), pp. 386-391.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[Ezetimibe-rosuvastatin fixed-dose combination (Myrosor®)].

  • Authors : Wallemacq C; Service de Diabétologie, Nutrition et Maladies métaboliques, CHU Liège, Belgique.; Scheen AJ

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/administration & dosage ; Ezetimibe*/Ezetimibe*/Ezetimibe*/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*

  • Source: Revue medicale de Liege [Rev Med Liege] 2020 Apr; Vol. 75 (4), pp. 260-264.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[Current update on PCKS9 inhibitors].

Subjects: Anticholesteremic Agents* ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Hypercholesterolemia*/Hypercholesterolemia*/Hypercholesterolemia*/drug therapy

  • Source: Revue medicale suisse [Rev Med Suisse] 2018 Feb 28; Vol. 14 (596), pp. 482-486.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].

Subjects: Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*drug therapy ; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control

  • Source: Revue medicale de Liege [Rev Med Liege] 2015 Sep; Vol. 70 (9), pp. 450-5.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
  • 1-10 of  51 results for ""Hydroxymethylglutaryl-CoA Reductase Inhibitors""